The Combination of ATRA and High-dose Dexamethasone as First-line Treatment in Adult Immune Thrombocytopenia
Status:
Completed
Trial end date:
2020-06-30
Target enrollment:
Participant gender:
Summary
Randomized, open-label, multicenter study to compare the efficacy and safety of ATRA plus
high-dose dexamethasone compared to high-dose dexamethasone monotherapy for the first-line
treatment of adults with primary immune thrombocytopenia (ITP).
Phase:
Phase 2
Details
Lead Sponsor:
Peking University People's Hospital
Collaborators:
Beijing Aerospace General Hospital Beijing Hospital Beijing Tongren Hospital Qilu Hospital of Shandong University The Sixth Medical Center of PLA General Hospital